Weekly update Companies AI-cruiter Recruiting service

MAIA Biotechnology

MAIA Biotechnology

Founded: 2018

Location: Chicago, IL

Employee range: 1 - 10

Clinical stage: Clin2

Therapy area: NSCLC

Drug types: ONC

Lead product: THIO-101 (partner: Regeneron)

Product link: https://maiabiotech.com/pipeline/

Funding: $5.75M stock Apr 2023; $10M IPO Jul 2022; $2.4M Mar 2022; $6M Oct 2021; $8M May 2021

maiabiotech.com

Short description:

Peptide Cancer Therapies

Drug notes:

THIO-102 Clin1 multiple cancers; THIO-103 Clin1 multiple cancers; 3 programs RD oncology

Long description:

Contact us to add description.

Jobs:

Main

Recruiting service

© 2023 Work In Biotech LLC

Terms of Service

Contact: recruit@workinbiotech.com